Moffitt Cancer Center and Research Institute is a clinical research site located in Tampa, Florida, United States 33612.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Moffitt Cancer Center and Research Institute has participated in 14 clinical trials with 3 currently active.
Therapeutic areas: Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer.
Sponsors: Calithera Biosciences, Inc, Taiho Oncology, Inc., Cellectar Biosciences, Inc..
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Moffitt Cancer Center and Research Institute has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Moffitt Cancer Center and Research Institute has 14 clinical trials on record, with 3 currently active. Their work covers Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer.
Moffitt Cancer Center and Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.